Vinva Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
24,835
-7,291
-23% -$497K 0.02% 278
2026
Q1
$2.91M Buy
32,126
+15,315
+91% +$1.08M 0.04% 251
2025
Q4
$1.7M Buy
16,811
+6,283
+60% +$423K 0.02% 267
2025
Q3
$1.17M Buy
10,528
+5,016
+91% +$333K 0.02% 307
2025
Q2
$441K Buy
5,512
+1,300
+31% +$74K 0.01% 363
2025
Q1
$428K Buy
4,212
+1,319
+46% +$76.6K 0.02% 334
2024
Q4
$223K Buy
+2,893
New +$148K 0.01% 398
2024
Q3
– Sell
-4,066
Closed -$315K – 432
2024
Q2
$315K Buy
+4,066
New +$178K 0.02% 391

Other funds holding HALO

Vinva Investment Management's HALO Position: Q2 2026 in Review

Vinva Investment Management reduced its Halozyme (HALO) stake by 23% in Q2 2026, selling an estimated $497K and leaving 24,835 shares worth $2.79M. The position accounts for 0.02% of the portfolio, ranked #278.

Vinva Investment Management first reported a position in HALO in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.91M in Q1 2026. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Vinva Investment Management held 24,835 shares of Halozyme worth $2.79M as of Q2 2026.
  • Vinva Investment Management sold 7,291 Halozyme shares in Q2 2026, an estimated $497K.
  • Halozyme made up 0.02% of Vinva Investment Management's portfolio in Q2 2026, its #278 holding.
  • Vinva Investment Management first reported a position in Halozyme in Q2 2024 and has held it in 8 quarters since.
  • Vinva Investment Management's Halozyme position peaked at $2.91M in Q1 2026.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.